Suppression of ChREBP not only decreased de novo nucleotide biosynthesis, but also activated p53 signaling in cancer cells.[24] Therefore, AGEs could regulate cell cycle and apoptosis by promoting ChREBP expression, increasing de novo nucleotide biosynthesis and activating p53. Here, TP53 is linked to cancer.